These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35749382)

  • 1. Bronchial epithelia from adults and children: SARS-CoV-2 spread via syncytia formation and type III interferon infectivity restriction.
    Beucher G; Blondot ML; Celle A; Pied N; Recordon-Pinson P; Esteves P; Faure M; Métifiot M; Lacomme S; Dacheux D; Robinson DR; Längst G; Beaufils F; Lafon ME; Berger P; Landry M; Malvy D; Trian T; Andreola ML; Wodrich H
    Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2202370119. PubMed ID: 35749382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2-infected primary human airway epithelia.
    Posch W; Vosper J; Noureen A; Zaderer V; Witting C; Bertacchi G; Gstir R; Filipek PA; Bonn GK; Huber LA; Bellmann-Weiler R; Lass-Flörl C; Wilflingseder D
    J Allergy Clin Immunol; 2021 Jun; 147(6):2083-2097.e6. PubMed ID: 33852936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses.
    Herder V; Dee K; Wojtus JK; Epifano I; Goldfarb D; Rozario C; Gu Q; Da Silva Filipe A; Nomikou K; Nichols J; Jarrett RF; Stevenson A; McFarlane S; Stewart ME; Szemiel AM; Pinto RM; Masdefiol Garriga A; Davis C; Allan J; Graham SV; Murcia PR; Boutell C
    PLoS Biol; 2021 Dec; 19(12):e3001065. PubMed ID: 34932557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the SARS-CoV-2 Host Response in Primary Human Airway Epithelial Cells from Aged Individuals.
    Subramaniyan B; Larabee JL; Bodas M; Moore AR; Burgett AWG; Myers DA; Georgescu C; Wren JD; Papin JF; Walters MS
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-Related Expression of IFN-λ1
    Gilbert C; Lefeuvre C; Preisser L; Pivert A; Soleti R; Blanchard S; Delneste Y; Ducancelle A; Couez D; Jeannin P
    Front Immunol; 2021; 12():750279. PubMed ID: 34858406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia.
    Pizzorno A; Padey B; Julien T; Trouillet-Assant S; Traversier A; Errazuriz-Cerda E; Fouret J; Dubois J; Gaymard A; Lescure FX; Dulière V; Brun P; Constant S; Poissy J; Lina B; Yazdanpanah Y; Terrier O; Rosa-Calatrava M
    Cell Rep Med; 2020 Jul; 1(4):100059. PubMed ID: 32835306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children.
    Loske J; Röhmel J; Lukassen S; Stricker S; Magalhães VG; Liebig J; Chua RL; Thürmann L; Messingschlager M; Seegebarth A; Timmermann B; Klages S; Ralser M; Sawitzki B; Sander LE; Corman VM; Conrad C; Laudi S; Binder M; Trump S; Eils R; Mall MA; Lehmann I
    Nat Biotechnol; 2022 Mar; 40(3):319-324. PubMed ID: 34408314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local and systemic responses to SARS-CoV-2 infection in children and adults.
    Yoshida M; Worlock KB; Huang N; Lindeboom RGH; Butler CR; Kumasaka N; Dominguez Conde C; Mamanova L; Bolt L; Richardson L; Polanski K; Madissoon E; Barnes JL; Allen-Hyttinen J; Kilich E; Jones BC; de Wilton A; Wilbrey-Clark A; Sungnak W; Pett JP; Weller J; Prigmore E; Yung H; Mehta P; Saleh A; Saigal A; Chu V; Cohen JM; Cane C; Iordanidou A; Shibuya S; Reuschl AK; Herczeg IT; Argento AC; Wunderink RG; Smith SB; Poor TA; Gao CA; Dematte JE; ; Reynolds G; Haniffa M; Bowyer GS; Coates M; Clatworthy MR; Calero-Nieto FJ; Göttgens B; O'Callaghan C; Sebire NJ; Jolly C; De Coppi P; Smith CM; Misharin AV; Janes SM; Teichmann SA; Nikolić MZ; Meyer KB
    Nature; 2022 Feb; 602(7896):321-327. PubMed ID: 34937051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I and III interferon responses in SARS-CoV-2 infection.
    Kim YM; Shin EC
    Exp Mol Med; 2021 May; 53(5):750-760. PubMed ID: 33953323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability of interferon-λ induction and antiviral activity in Nipah virus infected differentiated human bronchial epithelial cells of two human donors.
    Sauerhering L; Müller H; Behner L; Elvert M; Fehling SK; Strecker T; Maisner A
    J Gen Virol; 2017 Oct; 98(10):2447-2453. PubMed ID: 28984239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation.
    Rajah MM; Bernier A; Buchrieser J; Schwartz O
    J Mol Biol; 2022 Mar; 434(6):167280. PubMed ID: 34606831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imiquimod Boosts Interferon Response, and Decreases ACE2 and Pro-Inflammatory Response of Human Bronchial Epithelium in Asthma.
    Nieto-Fontarigo JJ; Tillgren S; Cerps S; Sverrild A; Hvidtfeldt M; Ramu S; Menzel M; Sander AF; Porsbjerg C; Uller L
    Front Immunol; 2021; 12():743890. PubMed ID: 34950134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia.
    Posch W; Vosper J; Zaderer V; Noureen A; Constant S; Bellmann-Weiler R; Lass-Flörl C; Wilflingseder D
    mBio; 2021 Apr; 12(2):. PubMed ID: 33906927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons.
    Jafarzadeh A; Nemati M; Saha B; Bansode YD; Jafarzadeh S
    Viral Immunol; 2021 Jun; 34(5):307-320. PubMed ID: 33147113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired type I and type III interferon induction and rhinovirus control in human cystic fibrosis airway epithelial cells.
    Vareille M; Kieninger E; Alves MP; Kopf BS; Möller A; Geiser T; Johnston SL; Edwards MR; Regamey N
    Thorax; 2012 Jun; 67(6):517-25. PubMed ID: 22213737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.
    Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P
    Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs.
    Sims AC; Baric RS; Yount B; Burkett SE; Collins PL; Pickles RJ
    J Virol; 2005 Dec; 79(24):15511-24. PubMed ID: 16306622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus.
    Qian Z; Travanty EA; Oko L; Edeen K; Berglund A; Wang J; Ito Y; Holmes KV; Mason RJ
    Am J Respir Cell Mol Biol; 2013 Jun; 48(6):742-8. PubMed ID: 23418343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.